Impairment of mitochondrial metabolism, particularly the electron transport chain (ETC), as well as increased oxidative stress might play a significant role in pathogenesis of Alzheimer's disease (AD). Some effects of drugs used for symptomatic AD treatment may be related to their direct action on mitochondrial function. In vitro effects of pharmacologically different cognitives (galantamine, donepezil, rivastigmine, 7-MEOTA, memantine) and nootropic drugs (latrepirdine, piracetam) were investigated on selected mitochondrial parameters: activities of ETC complexes I, II + III, and IV, citrate synthase, monoamine oxidase (MAO), oxygen consumption rate, and hydrogen peroxide production of pig brain mitochondria. Complex I activity was decreased by galantamine, donepezil, and memantine; complex II + III activity was increased by galantamine. None of the tested drugs caused significant changes in the rate of mitochondrial oxygen consumption, even at high concentrations. Except galantamine, all tested drugs were selective MAO-A inhibitors. Latrepirdine, donepezil, and 7-MEOTA were found to be the most potent MAO-A inhibitors. Succinate-induced mitochondrial hydrogen peroxide production was not significantly affected by the drugs tested. The direct effect of cognitives and nootropics used in the treatment of AD on mitochondrial respiration is relatively small. The safest drugs in terms of disturbing mitochondrial function appear to be piracetam and rivastigmine. The MAO-A inhibition by cognitives and nootropics may also participate in mitochondrial neuroprotection. The results support the future research aimed at measuring the effects of currently used drugs or newly synthesized drugs on mitochondrial functioning in order to understand their mechanism of action.
- Klíčová slova
- Cognitives, Mitochondrial respiration, Monoamine oxidase, Nootropics, Reactive oxygen species,
- MeSH
- Alzheimerova nemoc metabolismus MeSH
- cholinesterasové inhibitory farmakologie MeSH
- donepezil MeSH
- galantamin metabolismus MeSH
- indany farmakologie MeSH
- kognice účinky léků MeSH
- memantin farmakologie MeSH
- mitochondrie účinky léků metabolismus MeSH
- monoaminoxidasa účinky léků metabolismus MeSH
- mozek účinky léků metabolismus MeSH
- nootropní látky farmakologie MeSH
- piperidiny farmakologie MeSH
- prasata MeSH
- rivastigmin farmakologie MeSH
- spotřeba kyslíku účinky léků MeSH
- zvířata MeSH
- Check Tag
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- Názvy látek
- cholinesterasové inhibitory MeSH
- donepezil MeSH
- galantamin MeSH
- indany MeSH
- memantin MeSH
- monoaminoxidasa MeSH
- nootropní látky MeSH
- piperidiny MeSH
- rivastigmin MeSH
